Haemophilus Influenzae Type Disease
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) [Phase 3]
Phase 3 trial evaluating a pentavalent DTP-HB-Hib vaccine for immunogenicity and safety has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-26Clinical Trial Update: Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Infanrix-IPV/Hib (DTPa-IPV/Hib) in healthy Indian infants has been withdrawn.
-
EMA withdrawal · 2008-09-10EMA Withdrawn: Quintanrix (Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
Quintanrix has been withdrawn from the market by GlaxoSmithKline Biologicals S.A., with the status indicating withdrawal for its diphtheria,…